Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
about
Clinical management of localized colon cancer with capecitabineRadiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesA Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerAdjuvant chemotherapy for rectal cancer: Is it needed?Management of colorectal cancerCurrent treatment of rectal cancer adapted to the individual patientReview of systemic therapies for locally advanced and metastatic rectal cancerIncidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trialsTP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial.The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careEffect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-AnalysisCurrent debate in the oncologic management of rectal cancer.Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer.Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.Colorectal cancer: from prevention to personalized medicine.Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancerEffect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancerOutcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06).Overview of radiation therapy for treating rectal cancer.Therapeutic approaches in the management of locally advanced rectal cancer.The emerging role of neoadjuvant chemotherapy for rectal cancerIndian Council of Medical Research consensus document for the management of colorectal cancer.Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiationFeasibility of image-guided radiotherapy for elderly patients with locally advanced rectal cancer.Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2-3 diarrhoeaA randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.Saudi Oncology Society clinical management guideline series. Colorectal cancer 2014Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancerPostoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapyCoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer.The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.Accuracy of computed tomography in nodal staging of colon cancer patientsGenetics, diagnosis and management of colorectal cancer (Review).Advances and challenges in treatment of locally advanced rectal cancer.Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysisJapanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
P2860
Q24611758-75F760A8-D589-4D5D-AE6E-3DCAB3C5DC50Q26738806-8813328B-41EF-4D4E-B6D5-6EBC2A074E97Q26739607-A14072B8-0893-4926-9993-26E3CFD6626AQ26775099-E0B3F1ED-59DE-48F9-BDD5-644EA702B042Q26823550-D277A52D-54C1-4F7A-95B1-664D634D984BQ26824553-8B5F31BA-01E7-46CD-A375-4161CB9A7514Q27021105-4C38F25F-F7AE-4CA7-B241-23C2440879DAQ27028095-5560A96F-D355-484E-8517-9978FBB88D03Q27853024-E56498B4-0D3F-4FDC-BB80-78B038ECCC98Q28066460-C953B9BE-8659-4886-88B6-8519BEE683B7Q28066866-002DCB37-54C0-4156-A450-D7544B0395D5Q28072948-8FAAEAF0-6FDD-499F-84E1-7C722D211414Q30252773-0C25D952-1B60-477C-9895-275C1017C884Q33413548-32FC6A45-9012-45E1-AD30-74638EB645E6Q33416945-EF89AF45-7E4D-4A86-B6DE-B7C023E8C629Q33735234-30D9EA3D-3E01-4AB1-A559-297C1929F302Q33918145-9179F328-D711-4B5B-B66A-7307F6EFEC41Q33919715-1C788F62-114C-46C3-94C3-39119F195EBFQ34043383-A5909A84-61DA-4226-B318-69AE67ED73EAQ34136267-FF93F0D3-2840-4317-9AAD-4C99B86B9569Q34234928-3EEB53C8-2A74-4570-9B90-E8CDF9B046D3Q34234935-85ACA576-C385-4D22-9962-73067722717BQ34368271-98327621-2CAE-40FD-91DA-3E20B5610263Q34499179-E16A82D8-640A-4185-8BFD-BB3725499147Q34963606-BA1083F2-50F8-463E-9C68-C73B065B17C0Q35073661-CA38A983-F672-455B-818C-F893CE68099DQ35129364-2219845F-DCFE-4E69-87CC-9FB2639EE9C6Q35183695-D2319772-D248-423E-A1F9-5A6ACED16192Q35419294-68C7D009-61B8-4A0B-BD7C-2E649F21C600Q35542484-A560804F-DA6D-415C-A6A6-1A2A55B54424Q35678065-DD4EFBE7-894B-4A84-84D9-28D9A78636AFQ35733020-20BCFE1D-80A8-4C7E-A95C-ACE86319E20DQ35814400-22D650B8-DF96-475A-B2EF-9215CC83CABCQ35847605-49AAE227-00FE-4F84-9A34-150CEC487C0EQ35867312-195DCD55-51E2-4133-9EE4-1AD36C458F5EQ35884764-2C7F4B62-C6B3-4E8B-AE4D-17A10A4F64E2Q35934455-D0A7D5EC-0610-4556-A21D-A1E1C2D2FB53Q36025983-00D07297-D3FB-4D1A-BA48-42557E878F88Q36056754-E97CD270-80D3-49E0-9695-F91B5F650867Q36300533-F71825D7-A361-4AE7-9812-D2764C9F69A9
P2860
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@ast
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@en
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@nl
type
label
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@ast
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@en
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@nl
prefLabel
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@ast
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@en
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@nl
P2093
P921
P1433
P1476
Chemoradiotherapy with capecit ...... on-inferiority, phase 3 trial.
@en
P2093
Axel Matzdorff
Christian Constantin
Deniz Gencer
Elisabeth Fritz
Erika Kettner
Frederik Wenz
Gernot Hartung
Hans Walter Lindemann
Hartmut Link
Iris Burkholder
P304
P356
10.1016/S1470-2045(12)70116-X
P577
2012-04-13T00:00:00Z